Chief Science Officer, Cambrex President, Snapdragon Chemistry, a Cambrex Company

Matthew began his career in chemistry more than 30 years ago developing continuous processes for the manufacture and purification of acrylates at the former Rohm & Haas company.  Matthew then moved to Columbia University and earned a PhD in Chemistry.  Upon graduating, Matthew returned to industry as a process development chemist at Merck Research Laboratories.  In 2006 Matthew moved to Amgen where he worked on the development of both batch and continuous manufacturing solutions for synthetic drug substances.  He also worked on the development of new manufacturing technologies for synthetic – biologic hybrid molecules.  In 2015, Matthew was a founding member Snapdragon Chemistry, Inc., a contract development firm specialized in continuous manufacturing technology.  He is author or inventor on more than 30 peer reviewed publications and patents, and numerous regulatory filings.  Matthew is driven by a passion for the development of new chemical technologies.